NPM1 and acute myeloid leukemia: Actinomycin D acts on NPM1 mutant-primed mitochondria by releasing mitochondrial DNA, activating cyclic GMP-AMP synthase signaling, producing reactive-oxygen species (ROS) that restores NB formation to drive TP53 activation and senescence of NPM1-mutated AML cells.